Boundless Bio
Boundless Bio (Nasdaq: BOLD) is a San Diego, California based clinical-stage, next-generation precision oncology company founded in 2018 to target extrachromosomal DNA (ecDNA) — circular, centromere-free DNA that carries high copy-number oncogene amplifications and is observed in roughly 17% of cancer patients, driving tumor heterogeneity and resistance to targeted therapy. Its proprietary Spyglass discovery platform, built on a suite of ecDNA+/- tumor models plus molecular analytics and imaging, identifies targets essential to ecDNA function, which the company drugs with small-molecule ecDNA-directed therapies (ecDTx). The clinical pipeline is led by BBI-940, a kinesin inhibitor targeting ecDNA segregation, in the Phase 1 KOMODO-1 trial in ER+/HER2- and TNBC-LAR breast cancer opened in February 2026, with earlier CHK1 (replication stress) and RNR (DNA assembly and repair) programs behind it; ECHO, its ecDNA diagnostic algorithm, reads ecDNA off routine clinical next-generation sequencing and is described by the company as the first ecDNA diagnostic used in clinical trials. Boundless Bio raised a $100M Series C co-led by Leaps by Bayer and RA Capital and listed on Nasdaq in 2024. It publishes no developer program, no product API, no SDKs and no API documentation of any kind; the only machine-readable surface on boundlessbio.com is the WordPress REST API (wp/v2), anonymously readable, which serves the corporate pages, the Leadership directory and the media library as JSON.
Boundless Bio publishes 10 APIs on the APIs.io network, including Comments API, Discovery API, Leadership API, and 7 more. Tagged areas include Company, Biotechnology, Oncology, Precision Medicine, and Drug Discovery.
Boundless Bio’s developer surface includes support, authentication, and 22 more developer resources.
Kin Score
APIs 10
Individual APIs this provider publishes, each with its own machine-readable definition.
Boundless Bio Comments API
The Comments API from Boundless Bio — 2 operation(s) for comments.
Boundless Bio Discovery API
The Discovery API from Boundless Bio — 4 operation(s) for discovery.
Boundless Bio Leadership API
The Leadership API from Boundless Bio — 2 operation(s) for leadership.
Boundless Bio Media API
The Media API from Boundless Bio — 3 operation(s) for media.
Boundless Bio Pages API
The Pages API from Boundless Bio — 2 operation(s) for pages.
Boundless Bio Posts API
The Posts API from Boundless Bio — 2 operation(s) for posts.
Boundless Bio Search API
The Search API from Boundless Bio — 1 operation(s) for search.
Boundless Bio Settings API
The Settings API from Boundless Bio — 1 operation(s) for settings.
Boundless Bio Taxonomy API
The Taxonomy API from Boundless Bio — 6 operation(s) for taxonomy.
Boundless Bio Users API
The Users API from Boundless Bio — 3 operation(s) for users.
Scroll for all 10
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Agentic Access 1
Recommended x-agentic-access execution contracts for AI agents.
Resources
Agent Surfaces 4
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 3
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 5
Properties that don't map to a standard resource type